The detection and management of vaginal atrophy;Dépistage et Prise en Charge de L'Atrophie Vaginale. Cette directive clinique a été examinée par le comité mixte Pratique clinique - gynécologie et Urogynécologie, et a été approuvée par Ie comité exécuti( et Ie Conseil de la Société des obstétriciens et gynéco/ogues du Canada

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 5, 2004, Pages 509-515

  Johnston, Shawna L ^a   Farrell, Scott A ^a   Bouchard, Céline ^a   Beckerson, Lo Ann ^a   Comeau, Margery ^a   Lefebvre, Guylaine ^a   Papaioannou, Alexandra ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; PELVIC EXAMINATION; VAGINA ATROPHY;

EID: 84971434643     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30663-6     Document Type: Article

References (40)

1. Losif CS, Batra S, Ek A, Astedt B Estrogen receptors in the female urinary tract. Am J Obstet Gynecol 1981, 141:817-820.
2. Smith P, Heimer GM, Norgren A, Ulmsten U Steroid hormone receptors in pelvic muscles and ligaments in women. Gynecol Obstet Invest 1990, 30:27-30.
3. Raz R, Stamm WE A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993, 329:753-757.
4. Griebling TL, Nygaard IE The role of estrogen replacement therapy in the management of urinary incontinence and urinary tract infection in postmenopausal women. Endocrinol Metab Clin North Am 1997, 26(2):347-360.
5. Fand JA, Cardozo L, McClish DK Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994, 83:112-116.
6. Kalogeraki A, Tamiolakis D, Relakis K, Karvelas K, Froudarakis G, Hassan E, et al. Cigarette smoking and vaginal atrophy in postmenopausal women. In Vivo 1996, 10:597-600.
7. Woolf SH, Battista RN, Anderson GM, Logan AG, Eel W Canadian Task Force on the Periodic Health Exam 1994, xxxvii. Canada Communication Group, Ottawa.
8. Van Geelen JM, van de Weijer PH, Arnolds HT Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years. Int Urogynecol J Pelvic Floor Dysfunct 2000, 11:9-14.
9. Stenberg A, Heimer G, Ulmsten U, Cnattingus S Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas 1996, 24:31-36.
10. Utian WH, Schiff I North American Menopause Society-Gallup Survey on women's knowledge, information sources, and attitudes to menopause and HRT. Menopause 1994, 1:39-48.
11. Foxman B Urinary tract infection in postmenopausal women. Curr Infect Dis Rep 1999, 1(4):367-370.
12. Pinkerton JV, Shifren JL, LaValleur J, Rosen A, Roesinger M, Siddhanti S Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women. Menopause 2003, 10:45-52.
13. Bachman GA, Nevadunsky NS Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000, 61:3090-3096.
14. Nilsson K, Risberg B, Heimer G The vaginal epithelium in the postmenopause - cytology, histology and PH as methods of assessment. Maturitas 1995, 21:51-56.
15. Leiblum S, Bachmann G, Kemmann E, Colburn D Schwartzman L Vaginal atrophy in the postmenopausal woman: the importance of sexual activity and hormones. JAMA 1983, 249:2195-2198.
16. Laan E, van Lunsen RHW Hormones and sexuality in postmenopausal women: a psychophysiological study. J Psychosom Obstet Gynecol 1997, 18:126-133.
17. Upmalis DH, Lobo R, Badley L, Warren M, Cone FL, Lamma CA Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized placebo-controlled trial. Menopause 2000, 7:236-242.
18. Hirate JD, Swiersz LM, Zell B, Small R, Ettinger B Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997, 68:981-986.
19. Jepson RG, Mihaljevich L, Craig J Cranberries for preventing urinary tract infections (Cochrane Review). In: The Cochrane Library 2003.
20. Kontiokari T, Sundqvist K, Nuutinen M PokkaT, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001, 322(7302):1571.
21. Bygdeman M, Swah ML Replens versus dlienoestrol cream in symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 1996, 23:259-263.
22. Nachtigall LE Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril 1994, 61:178-180.
23. Cardozo L, Bachmann G, McClish D, Fonda D Birgerson L Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormone and urogenital therapy committee. Obstet Gynecol 1998, 92:722-727.
24. Rioux JE, Devlin MC, Gelfand MM, Steinberg WM, Hepburn DS 17-ß-Estradiol vaginal tablets versus conjugated equine estrogen cream to relieve menopausal atrophic vaginitis. Menopause 2000, 7:156-161.
25. Casper F, Petri E Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal ring study group. Int Urogynecol J Pelvic Floor Dysfunct 1999, 10:171-176.
26. Handa VL, Bachus KE, Johnston WW, Robboy SJ, Hammond CB Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol 1994, 84:215-218.
27. Mandel FP, Geola FL, Meldrum DR, Lu JH, Eggena P, Sambhi MP, et al. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1983, 57:133-139.
28. Johnston A Estrogens: pharmacokinetics and pharmacodynamics with special reference to vaginal administration and the new estradiol formulation-Estring. Acta Obstet Gynecol Scand 1996, 75(Suppl 163):16-25.
29. Botsis D, Kassanos D, Kalogirou D, Antoniou G, Vitoratos N, Karakitsos P Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low-dose estrogen or tibilone treatment: a comparison. Maturitas 1997, 26:57-62.
30. Mattsson LA Cullberg G. Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women. Acta Obstet Gynecol Scand 1983, 62:393-396.
31. Losif CS Effects of protracted administration of estriol on the lower genitourinary tract in postmenopausal women. Arch Gynaecol Obstet 1992, 251:115-120.
32. Smith R Heimer G, Lindskog M, Ulmsten U Oestradiol-releasing vaginal ring for the treatment of postmenopausal urogenital atrophy. Maturitas 1993, 16:145-154.
33. Henriksson L, Stjernquist M, Boquist L, Cedergren I, Sellinus I A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996, 174:85-92.
34. Nachtigall LE Clinical trial of estradiol vaginal ring in the United States. Maturitas 1995, 22(Suppl):S43-S47.
35. Eriksen PS, Rasmussen H Low-dose 17ß-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 1992, 44:137-144.
36. Mettler L, Olsen PG Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets. Maturitas 1991, 14:23-31.
37. Mattsson LA, Cullberg G, Eriksson O Knutsson EVaginal administration of low-dose oestradiol - effects on the endometrium and vaginal cytology. Maturitas 1989, 11:217-222.
38. Lahti E, Vuopala S, Kauppila A, Blanco G, Roukonen A LaatikainenT. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Gynecol Oncol 1994, 55:410-414.
39. Parsons A, Merrit D, Rosen A, Heath H, Siddhanti S Plouffe L Study groups on the effects of raloxifene HCl with low-dose premarin vaginal cream. Obstet Gynecol 2003, 101:346-352.
40. Eriksen BC A randomized, open, parallel-group study on the preventative effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999, 180:1072-1079.